Nature

Brain injury following mild hypoxic-ischemic encephalopathy in neonates–Ten-year experience in a tertiary perinatal center

This was a single-center, retrospective study of mild HIE conducted from 2011 to 2020. Almost all neonates with mild HIE received management targeted to a temperature of 36 ± 0.5°C for 72 h and ...
Nature

Signal amid noise—quantitative electroencephalography for stratification and early outcome prediction in neonatal hypoxic ischemic encephalopathy

Therapeutic hypothermia is central to the care of newborns with suspected hypoxic-ischemic encephalopathy (HIE). While this treatment has been shown to reduce the risk of subsequent death or ...

Birth Injury Justice Center Says Hospital Delays in HIE Treatment May Be Medical Negligence

Cooling therapy may reduce the risk of death or disability in babies with HIE, but treatment must begin within hours of birth. BOSTON, MA / ACCESS Newswire / June 24, 2026 / In the minutes and hours ...
Medical Xpress

MRI study examines overlap between two common neonatal brain injuries

Brain injuries are a leading cause of death and long-term disability in infants. Among the most common is neonatal hypoxic-ischemic encephalopathy (HIE), which affects one to three in 1,000 live ...
MedPage Today

Adding Erythropoietin Did Not Reduce Death, Disability in Neonatal HIE

Adding a high dose of erythropoietin to therapeutic hypothermia did not reduce rates of death or disability in infants with neonatal hypoxic ischemic encephalopathy (HIE), a phase III randomized trial ...
Business Wire

ReAlta Life Sciences Doses First Patient in Phase 2 STAR-Study of RLS-0071 for Hypoxic Ischemic Encephalopathy in Newborns

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences (“ReAlta”), Inc., a clinical mid-stage biotech company dedicated to addressing life-threatening rare diseases by harnessing the power of the immune ...